Log In
Print this Print this

CD3 x CD20

  Manage Alerts
Collapse Summary General Information
Company Xencor Inc.
DescriptionBispecific antibodies against CD3 and CD20
Molecular Target CD3 ; CD20
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today